Viral Hepatitis
18
3
5
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
22%
4 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (18)
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection
A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection
Repeatability and Reproducibility of Multiparametric MRI
Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®
VIRal Hepatitis and GAllstone Disease Study
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus
Seroepidemiology of Viral Hepatitis in Hong Kong
Continuing Medical Education to Improve Knowledge of Viral Hepatitis B-C in Primary Healthcare Workers
A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases
Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid
Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy
Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan
Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases
Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity
Prognostic Indicators as Provided by the EPIC ClearView
Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.